An Economic Evaluation Supported by Qualitative Data About the Patient Concerns Inventory (PCI) versus Standard Treatment Pathway in the Management of Patients with Head and Neck Cancer.

MLA

Ezeofor, Victory ’Segun, et al. “An Economic Evaluation Supported by Qualitative Data About the Patient Concerns Inventory (PCI) versus Standard Treatment Pathway in the Management of Patients with Head and Neck Cancer.” PharmacoEconomics - Open, vol. 6, no. 3, May 2022, pp. 389–403. EBSCOhost, https://doi.org/10.1007/s41669-021-00320-4.

APA

Ezeofor, V. ’Segun, Spencer, L. H., Rogers, S. N., Kanatas, A., Lowe, D., Semple, C. J., Hanna, J. R., Yeo, S. T., & Edwards, R. T. (2022). An Economic Evaluation Supported by Qualitative Data About the Patient Concerns Inventory (PCI) versus Standard Treatment Pathway in the Management of Patients with Head and Neck Cancer. PharmacoEconomics - Open, 6(3), 389–403. https://doi.org/10.1007/s41669-021-00320-4

Chicago

Ezeofor, Victory ’Segun, Llinos Haf Spencer, Simon N Rogers, Anastasios Kanatas, Derek Lowe, Cherith J Semple, Jeffrey R Hanna, Seow Tien Yeo, and Rhiannon Tudor Edwards. 2022. “An Economic Evaluation Supported by Qualitative Data About the Patient Concerns Inventory (PCI) versus Standard Treatment Pathway in the Management of Patients with Head and Neck Cancer.” PharmacoEconomics - Open 6 (3): 389–403. doi:10.1007/s41669-021-00320-4.